| Chamara Harris, LBSW-IPR, LPC | |
|
15222 Snow Hill Ct, Sugar Land, TX 77498-2150 | |
| (832) 275-2673 | |
| Not Available |
| Full Name | Chamara Harris |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 15222 Snow Hill Ct, Sugar Land, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033463229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 60459 (Texas) | Secondary |
| 1041C0700X | Social Worker - Clinical | 35768 (Texas) | Primary |
| Entity Name | Senior Psychological Care I Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245526490 PECOS PAC ID: 1557535226 Enrollment ID: O20111114000881 |
News Archive
DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.
In the run up to November's midterm elections, President Obama will tout the new health law, hoping the consumer-friendly provisions taking effect this week will help erode ill will toward the overhaul, The Wall Street Journal reports. "Starting Thursday, insurers officially must adhere to about a half-dozen key changes under the law, including eliminating co-payments for preventive services and allowing children to stay on their parents' insurance policy until their 26th birthday.
AIDS Healthcare Foundation (AHF) has criticized Merck and Co. Pharmaceuticals, for the announced price for its key new HIV/AIDS drug, Isentress (raltegravir), an integrase inhibitor approved by the Food and Drug Administration (FDA) Friday, and priced by the company at nearly $9,900 per patient yearly.
A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the University of Pennsylvania's Perelman School of Medicine.
NPR reports on the immediate effects of the proposed health care bill, and that Congressional Democrats are focusing on those benefits in messages to constituents. "The White House is trying to shift the conversation away from the messy legislative process — which Republicans are keying on — and instead focus on what the health care overhaul would do for families and businesses."
› Verified 1 days ago
| Entity Name | Encounter Telehealth, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922342195 PECOS PAC ID: 9931348307 Enrollment ID: O20170512001047 |
News Archive
DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.
In the run up to November's midterm elections, President Obama will tout the new health law, hoping the consumer-friendly provisions taking effect this week will help erode ill will toward the overhaul, The Wall Street Journal reports. "Starting Thursday, insurers officially must adhere to about a half-dozen key changes under the law, including eliminating co-payments for preventive services and allowing children to stay on their parents' insurance policy until their 26th birthday.
AIDS Healthcare Foundation (AHF) has criticized Merck and Co. Pharmaceuticals, for the announced price for its key new HIV/AIDS drug, Isentress (raltegravir), an integrase inhibitor approved by the Food and Drug Administration (FDA) Friday, and priced by the company at nearly $9,900 per patient yearly.
A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the University of Pennsylvania's Perelman School of Medicine.
NPR reports on the immediate effects of the proposed health care bill, and that Congressional Democrats are focusing on those benefits in messages to constituents. "The White House is trying to shift the conversation away from the messy legislative process — which Republicans are keying on — and instead focus on what the health care overhaul would do for families and businesses."
› Verified 1 days ago
| Entity Name | Bmsc Tx Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215485198 PECOS PAC ID: 1052680949 Enrollment ID: O20170710000725 |
News Archive
DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.
In the run up to November's midterm elections, President Obama will tout the new health law, hoping the consumer-friendly provisions taking effect this week will help erode ill will toward the overhaul, The Wall Street Journal reports. "Starting Thursday, insurers officially must adhere to about a half-dozen key changes under the law, including eliminating co-payments for preventive services and allowing children to stay on their parents' insurance policy until their 26th birthday.
AIDS Healthcare Foundation (AHF) has criticized Merck and Co. Pharmaceuticals, for the announced price for its key new HIV/AIDS drug, Isentress (raltegravir), an integrase inhibitor approved by the Food and Drug Administration (FDA) Friday, and priced by the company at nearly $9,900 per patient yearly.
A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the University of Pennsylvania's Perelman School of Medicine.
NPR reports on the immediate effects of the proposed health care bill, and that Congressional Democrats are focusing on those benefits in messages to constituents. "The White House is trying to shift the conversation away from the messy legislative process — which Republicans are keying on — and instead focus on what the health care overhaul would do for families and businesses."
› Verified 1 days ago
| Entity Name | Harris County Mih Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861072647 PECOS PAC ID: 8628487410 Enrollment ID: O20210507000029 |
News Archive
DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.
In the run up to November's midterm elections, President Obama will tout the new health law, hoping the consumer-friendly provisions taking effect this week will help erode ill will toward the overhaul, The Wall Street Journal reports. "Starting Thursday, insurers officially must adhere to about a half-dozen key changes under the law, including eliminating co-payments for preventive services and allowing children to stay on their parents' insurance policy until their 26th birthday.
AIDS Healthcare Foundation (AHF) has criticized Merck and Co. Pharmaceuticals, for the announced price for its key new HIV/AIDS drug, Isentress (raltegravir), an integrase inhibitor approved by the Food and Drug Administration (FDA) Friday, and priced by the company at nearly $9,900 per patient yearly.
A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the University of Pennsylvania's Perelman School of Medicine.
NPR reports on the immediate effects of the proposed health care bill, and that Congressional Democrats are focusing on those benefits in messages to constituents. "The White House is trying to shift the conversation away from the messy legislative process — which Republicans are keying on — and instead focus on what the health care overhaul would do for families and businesses."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chamara Harris, LBSW-IPR, LPC 15222 Snow Hill Ct, Sugar Land, TX 77498-2150 Ph: (832) 275-2673 | Chamara Harris, LBSW-IPR, LPC 15222 Snow Hill Ct, Sugar Land, TX 77498-2150 Ph: (832) 275-2673 |
News Archive
DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.
In the run up to November's midterm elections, President Obama will tout the new health law, hoping the consumer-friendly provisions taking effect this week will help erode ill will toward the overhaul, The Wall Street Journal reports. "Starting Thursday, insurers officially must adhere to about a half-dozen key changes under the law, including eliminating co-payments for preventive services and allowing children to stay on their parents' insurance policy until their 26th birthday.
AIDS Healthcare Foundation (AHF) has criticized Merck and Co. Pharmaceuticals, for the announced price for its key new HIV/AIDS drug, Isentress (raltegravir), an integrase inhibitor approved by the Food and Drug Administration (FDA) Friday, and priced by the company at nearly $9,900 per patient yearly.
A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the University of Pennsylvania's Perelman School of Medicine.
NPR reports on the immediate effects of the proposed health care bill, and that Congressional Democrats are focusing on those benefits in messages to constituents. "The White House is trying to shift the conversation away from the messy legislative process — which Republicans are keying on — and instead focus on what the health care overhaul would do for families and businesses."
› Verified 1 days ago